Corporate influence over planning and presentation of clinical trials: beauty and the beast.
Fuchs
Flávio Danni
FD
D002317:Cardiovascular Agents / Q000191:economics / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004345:Drug Industry / Q000191:economics / Q000941:ethics / Q000458:organization & administration*; D006801:Humans; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic / Q000941:ethics / Q000379:methods*
D002317:Cardiovascular Agents